頭頸部がん治療薬の世界市場は、2022 年から 2027 年までに 8.5% のCAGRで拡大し、2022 年の 17 億ドルから 2027 年には 26 億ドルに増加すると予想されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table 0A : Global Market for Head and Neck Cancer Therapeutics, by Diagnostic Method, Through 2027
Figure 0A : Global Market for Head and Neck Cancer Therapeutics, by Diagnostic Method, 2020-2027
Table 0B : Global Market for Head and Neck Cancer Therapeutics, by Disease Indication, Through 2027
Figure 0B : Global Market for Head and Neck Cancer Therapeutics, by Disease Indication, 2020-2027
Chapter- 3: Market and Technology Background
Head and Neck Cancer Overview
Incidence
Stages of Head and Neck Cancer
Risk Factors
Symptoms
Blockbuster Drugs
Chapter- 4: Regulatory Structure
Regulatory Challenges for Selected Countries
Chapter- 5: Market Breakdown, by Diagnostic Method
Diagnostic Methods
Chapter- 6: Market Breakdown, by Treatment Type
Overview
Treatment Types
Chapter- 7: Market Breakdown, by Disease Indication
Overview
Disease Indications
Chapter- 8: Market Breakdown, by Route of Administration
Overview
Route of Administration
Chapter- 9: Market Breakdown, by Therapeutic Class
Overview
Therapeutic Classes
Chapter- 10: Market Breakdown, by End User
Overview
End Users
Chapter- 11: Market Dynamics
Market Drivers
Market Challenges
Chapter- 12: Impact of COVID-19 on the Market
Overview
Impact of COVID-19 on Head and Neck Cancer Therapeutics
Chapter- 13: Pipeline Analysis
Overview
Chapter- 14: Competitive Landscape
Overview
Global Company Ranking
Chapter- 15: Company Profiles
ABBVIE INC.
ASTRAZENECA PLC
BAYER AG
BRISTOL-MYERS SQUIBB
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
PFIZER INC.
MERCK & CO.
SANOFI-AVENTIS
